Atormac
Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 1364  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
 Search
 
  
 Resource Links
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Article in PDF (266 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this Article
   References

 Article Access Statistics
    Viewed875    
    Printed44    
    Emailed0    
    PDF Downloaded24    
    Comments [Add]    

Recommend this journal

 


 
Table of Contents    
CORRESPONDENCE
Year : 2011  |  Volume : 59  |  Issue : 5  |  Page : 795

Authors' reply


Department of Neurology, Gauhati Medical College, Guwahati, Assam, India

Date of Web Publication22-Oct-2011

Correspondence Address:
A K Kayal
Department of Neurology, Gauhati Medical College, Guwahati, Assam
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions



How to cite this article:
Kayal A K, Goswami M, Das M, Paul B. Authors' reply. Neurol India 2011;59:795

How to cite this URL:
Kayal A K, Goswami M, Das M, Paul B. Authors' reply. Neurol India [serial online] 2011 [cited 2019 Jul 16];59:795. Available from: http://www.neurologyindia.com/text.asp?2011/59/5/795/86588


Sir,

Thank you for the interest in our article on the clinical spectrum of neurosyphilis. [1],[2] We have used the diagnostic criteria as suggested by Pope and Steiner. [3] Even in the article by Workoswki et al.,[4] it is mentioned that "The venereal disease research laboratory in cerebrospinal fluid (CSF VDRL), which is highly specific but insensitive, is the standard serologic test for CSF. When reactive in the absence of substantial contamination of CSF with blood, it is considered diagnostic of neurosyphilis". Therefore the laboratory diagnosis of neurosyphilis usually depends on various combinations of reactive serologic test results, CSF cell count or protein; and a reactive CSF VDRL with or without clinical manifestations. In our series blood VDRL and CSF VDRL was done in all the patients. In addition blood TPHA was also done in 14 of 16 patients and all these patients were positive. CSF fluorescent treponemal antibody - absorbtion, CSF TPHA though sensitive are not routinely available.

 
  References Top

1.Joob B, Wiwanitkit V. Clinical spectrum of neurosyphilis in North East India. Neurol India 2011;59:794-5.  Back to cited text no. 1
  Medknow Journal  
2.Kayal AK, Goswami M, Das M, Paul B. Clinical spectrum of neurosyphilis in North East India. Neurol India 2011;59:344-50.  Back to cited text no. 2
[PUBMED]  Medknow Journal  
3.Pope V, Steiner BM. Syphilis. In: Hiscox JA, editor. Topley and Wilson's microbiology and microbial infection, 10 th ed. New York: Wiley and Blackwell; 2007. p. 1838-64.  Back to cited text no. 3
    
4.Workowski KA, Berman S; Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 2010;59:1-110.  Back to cited text no. 4
    




 

Top
Print this article  Email this article
   
Online since 20th March '04
Published by Wolters Kluwer - Medknow